Elsevier

Journal of Hepatology

Volume 75, Issue 1, July 2021, Pages 251-254
Journal of Hepatology

Letter to the Editor
Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings

https://doi.org/10.1016/j.jhep.2021.02.024Get rights and content

Keywords

hepatitis C virus
direct-acting antivirals
retreatment
salvage therapy
glecaprevir/pibrentasvir
sofosbuvir
ribavirin

Cited by (0)

View Abstract